Pangea Bio

Drug Discovery · Kent, United Kingdom · Founded 2021 · Privately Held (backing)

Developer of a novel medicines platform designed to treat neurological disorders. Pangea Bio is based in Kent, United Kingdom and was founded in 2021. It was valued at $80 million at its early-stage round in Oct 2024, the last priced event on record. It has raised $21.7 million across 1 recorded round; the latest was a $15.6 million Series A in Oct 2023.

PMV mark · valuation
$80.0M
Oct 2026
Priced at
its early-stage round
Oct 2024
Total raised
$21.7M
Last round
Early Stage VC (Series A)
Oct 2023

Who backs Pangea Bio?

19 investors
InvestorType
Plug and Play Tech Center—
Innovate UKOther
Metaplanet HoldingsVenture capital
London & Partners.Other
Hub71Other
One MindOther
Alzheimers Drug Discovery Foundation—
Einstein Biotech Innovation—
Grow London—
Kadmos Capital—
+ 9 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Pangea Bio investors

19 investors are on record for Pangea Bio, including Plug and Play Tech Center, Innovate UK, Metaplanet Holdings and London & Partners.. The Series A in Oct 2023 drew 4 investors.

Free account
More of Pangea Bio with a free account
  • ·The complete investor list: 19 names
  • ·Watch Pangea Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 19 firms already write checks for companies like Pangea Bio in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View